Rapid Top-Down Analysis of the NISTmAb antibody
Others | 2020 | BrukerInstrumentation
MALDI, LC/TOF, LC/MS
IndustriesClinical Research
ManufacturerBruker
Key wordsbruker, terminal, spot, sequence, top, down, biganchorchip, maldi, rapid, modification, flashnote, pyroglu, fragments, mtp, termini, protein, nistmab, daltonik, elucidate, llc, daltonics, bremen, therapeutics, recombinant, reserves, twice, unexpected, continually, covered, method, let, acn, can, saving, gmbh, looking, manufacturer, therapeutic, modifications, read, antibody, verification, cut, verify, filters, status, matching, challenge, improving, dry
Similar PDF
Extensive LC-Top-Down MS Sequence Confirmation of the NISTmAb Reference Material 8671
2018|Bruker|Applications
Extensive LC-Top-Down MS Sequence Confirmation of the NISTmAb Reference Material 8671 Characterization of therapeutic antibodies aims on primary sequence validation, localization of modifications such as glycan profiles and the determination of disulfide bond status of the target molecule. Introduction Typically,…
Key words
maldi, maldispoton, spotontds, tdsbruker, brukersequence, sequencetof, tofnistmab, nistmabterminal, terminalides, idestop, topisd, isdrapiflex, rapiflexdown, downanchorchip, anchorchipsdhb
Recombinant SARS-CoV-2 Receptor Binding Domain: Comprehensive Top-Down Sequence Confirmation, Curation and O-Glycosylation Site Determination
2021|Bruker|Applications
Recombinant SARS-CoV-2 Receptor Binding Domain: Comprehensive Top-Down Sequence Confirmation, Curation and O-Glycosylation Site Determination Know your SARS-CoV-2 antigen structure before it´s use in research and diagnostics Abstract The COVID pandemic dramatically influences our life and the demand remains very high…
Key words
maldi, maldiisd, isdrbd, rbdglycosylation, glycosylationbruker, brukerrbds, rbdsterminal, terminalsialexo, sialexosequence, sequencepngase, pngasedown, downspectra, spectracho, chocompass, compasstop
Next-generation MALDI top-down sequencing of protein biotherapeutics – expanding the scope of timsTOF technology
2021|Bruker|Applications
Next-generation MALDI top-down sequencing of protein biotherapeutics – expanding the scope of timsTOF technology Next-generation MALDI top-down sequencing (MALDI-TDS) improves top-down sequence analysis of biopharmaceutical proteins, as demonstrated in this note for adalimumab subunits, recombinant SARS-CoV-2 S-glycoprotein RBD expression products,…
Key words
maldi, malditds, tdsterminal, terminalisd, isdtims, timsnext, nextgeneration, generationsequence, sequencesequencing, sequencingprotein, proteintimstof, timstoffragments, fragmentssubunits, subunitsdown, downflex
Automated High-Throughput Clone Screening of Therapeutic Antibodies: From Automated IdeS Digestion to Intact Fc/2-Glycosylation Analysis by MALDI-TOF
2020|Bruker|Applications
Automated High-Throughput Clone Screening of Therapeutic Antibodies: From Automated IdeS Digestion to Intact Fc/2-Glycosylation Analysis by MALDI-TOF The glycosylation status of the Fc/2 region is a critical quality attribute (CQA) of therapeutic antibodies and is typically tested in early stages…
Key words
maldi, maldidhap, dhapbruker, brukerdac, dacbeads, beadsdigestion, digestionintensility, intensilityglycan, glycanides, idesscreening, screeningplate, platetof, tofsample, sampleautoflex, autoflexprotocol